Gastroenterology (all articles)
Review: Gastrointestinal post-acute COVID-19 syndrome.
11 Apr, 2022 | 01:49h | UTCGastrointestinal post-acute COVID-19 syndrome – Nature Reviews Gastroenterology & Hepatology
Commentary on Twitter
NEW! COMMENT
Gastrointestinal post-acute COVID-19 syndromehttps://t.co/SDAOnQSEp4#COVID19 #LongCovid pic.twitter.com/CUSoUt0azy
— Nature Reviews Gastroenterology & Hepatology (@NatRevGastroHep) April 9, 2022
Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.
8 Apr, 2022 | 10:58h | UTCInvited Commentary: Global epidemiology and prevention of colorectal cancer – The Lancet Gastroenterology & Hepatology (free registration required)
Case-cohort study: The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China.
7 Apr, 2022 | 08:22h | UTCCommentary: Helicobacter pylori infection and risk of gastric cancer – The Lancet Public Health
Review: Mechanisms of action of current pharmacologic options for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
7 Apr, 2022 | 08:14h | UTC
Systematic Review: Epidemiology of musculoskeletal manifestations in pediatric inflammatory bowel disease.
7 Apr, 2022 | 07:55h | UTC
RCT: Higher vs. Standard Adalimumab induction and maintenance dosing regimens for treatment of ulcerative colitis.
6 Apr, 2022 | 09:56h | UTC
Podcast: Acute pancreatitis pearls.
5 Apr, 2022 | 08:26h | UTC#327 Acute Pancreatitis – The Curbsiders
Review: Treatment strategies to improve outcomes in patients with chronic idiopathic constipation and irritable bowel syndrome with constipation.
5 Apr, 2022 | 08:00h | UTC
ACG Guideline: Diagnosis and management of Barrett’s esophagus.
4 Apr, 2022 | 01:07h | UTC
Nature Outlook: Hepatitis B.
31 Mar, 2022 | 08:05h | UTCHomepage: Nature Outlook: Hepatitis B
Closing in on a cure for hepatitis B
Developing a cure for chronic hepatitis B requires a fresh approach
How to stop mother-to-child transmission of hepatitis B
Simplify access to hepatitis B care
Facing the challenge of eliminating hepatitis B
The global fight against hepatitis B is benefitting some parts of the world more than others
Africa’s struggle with hepatitis B
Why hepatitis B hits Aboriginal Australians especially hard
Hepatitis B and the liver cancer endgame
Research round-up: hepatitis B
Charting a new frontier in chronic hepatitis B research to improve lives worldwide
Addressing the unmet need for a functional cure for chronic hepatitis B
Systematic Review: Evidence-based efficacy of methotrexate in adult Crohn’s disease in different intestinal and extraintestinal indications.
31 Mar, 2022 | 07:50h | UTC
SEOM clinical guideline: chemotherapy-induced nausea and vomiting.
31 Mar, 2022 | 07:45h | UTCSEOM clinical guideline emesis (2021) – Clinical and Translational Oncology
Related:
Prevention of Chemotherapy-induced nausea and vomiting in the older patient: optimizing outcomes.
Retrospective Cohort Study: Risks for anaphylaxis with intravenous iron formulations.
30 Mar, 2022 | 10:16h | UTCRisks for Anaphylaxis With Intravenous Iron Formulations: A Retrospective Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)
News Release: Risk of Severe Allergic Reaction Higher with Two Intravenous Iron-Boosting Products – Rutgers University
Commentary: Risks for Anaphylaxis Compared Among IV Iron Products – HealthDay
Systematic Review: Probiotics for treatment of chronic constipation in children.
30 Mar, 2022 | 10:12h | UTCProbiotics for treatment of chronic constipation in children – Cochrane Library
Summary: Probiotics for treatment of chronic constipation in children – Cochrane Library
Meta-analysis of randomized trials: GLP1 receptor agonists increase the risk of gallbladder and biliary diseases (RR, 1.37; 95% CI, 1.23-1.52).
29 Mar, 2022 | 10:02h | UTCAssociation of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials – JAMA Internal Medicine (free for a limited period)
Commentary: GLP-1 Receptor Agonists: How Safe Are They for the Gallbladder?— Link with gallbladder, biliary diseases could be due to weight loss associated with class of drug – MedPage Today (free registration required)
AGA clinical practice update on the role of diet in irritable bowel syndrome.
28 Mar, 2022 | 10:04h | UTCRelated:
10 mistakes in dietary management of irritable bowel syndrome and how to avoid them.
Supplement: Irritable bowel syndrome and related conditions.
RCT: FODMAPs, but not gluten, elicit modest symptoms of irritable bowel syndrome.
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Guidelines for the treatment of irritable bowel syndrome
ACG Clinical Guideline: Management of irritable bowel syndrome
M-A: Efficacy of a low-FODMAP diet in adult irritable bowel syndrome
Review: Surgical risk assessment in patients with chronic liver diseases.
25 Mar, 2022 | 08:46h | UTC
Commentary on Twitter
Surgical Risk Assessment in Patients With Chronic Liver Diseases https://t.co/us01T2XsxE
— Journal of Clinical and Experimental Hepatology (@JCEH_Hepatology) March 23, 2022
Food protein-induced enterocolitis syndrome: A large French multicentric experience.
25 Mar, 2022 | 08:27h | UTC
Observational study suggests antidopaminergic antiemetics (domperidone, metopimazine, and metoclopramide) are associated with increased stroke risk.
24 Mar, 2022 | 09:51h | UTCNews Release: Widely used nausea drugs linked to heightened risk of stroke – BMJ
Review: Diagnosis and management of secondary causes of steatohepatitis.
23 Mar, 2022 | 09:59h | UTCDiagnosis and management of secondary causes of steatohepatitis – Journal of Hepatology
Review: Extrahepatic manifestations in alcoholic liver disease.
23 Mar, 2022 | 09:44h | UTCExtrahepatic Manifestations in Alcoholic Liver Disease – Journal of Clinical and Experimental Hepatology (free for a limited period)
Review: Management of alcohol withdrawal syndrome in patients with alcoholic liver disease.
23 Mar, 2022 | 09:46h | UTCManagement of Alcohol Withdrawal Syndrome in Patients with Alcoholic Liver Disease – Journal of Clinical and Experimental Hepatology (free for a limited period)
Review: Current medical treatment for alcohol-associated liver disease.
23 Mar, 2022 | 09:43h | UTCCurrent Medical Treatment for Alcohol-Associated Liver Disease – Journal of Clinical and Experimental Hepatology (free for a limited period)
Review: Management of portal hypertension.
23 Mar, 2022 | 09:42h | UTCManagement of Portal Hypertension – Journal of Clinical and Experimental Hepatology
Review: Diagnosis and management of cirrhotic cardiomyopathy.
23 Mar, 2022 | 09:41h | UTC